Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
Neomorph is building out its supply of pharma partnerships, stamping down an option-to-license pact with AbbVie centered on molecular glue degraders.
Gabrielle Masson
Jan 23, 2025 9:58am
Takeda's R&D head shares 'new way of working'
Jan 21, 2025 4:48pm
JPM25: GSK's CSO shares science strategy behind deal-heavy year
Jan 15, 2025 12:58am
JPM25: M&A strategist GSK acquires IDRx for $1B upfront
Jan 13, 2025 2:00am
Gilead roars into JPM25 with $250M upfront deal for Leo
Jan 11, 2025 5:30pm
Right out of the gate, Light Horse nabs $62M and Novartis deal
Jan 9, 2025 4:26pm